Hurun India Rich List 2026 edition
Rank#223- Wealth
- ₹16,700 Cr
- Company
- Dr. Reddy's Laboratories
Current companies 22 active board seats
Past companies 29 historical roles
Total affiliations 51 Since Jan 1993
Shareholding value •••• Premium profile
About Satish Reddy Kallam
Data last updated:
Satish Reddy Kallam has 33 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 22 companies, including Dr. Reddy's Bio-Sciences Limited and Dr.Reddy's Laboratories Ltd. Formerly with 29 companies, such as Zenfold Ventures Llp and Proline Real Estates Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 15 current companies with reported revenue have a combined latest revenue of ₹35,709 Cr; the largest is Dr.Reddy's Laboratories Ltd at ₹35,059 Cr (FY 2026).
K Satish Reddy and family are #223 on the Hurun India Rich List 2026, with wealth of ₹16,700 Cr.
DIN 00129701
Primary Designation Director
First Appointment 18 Jan 1993
Oldest Company Age 42 yrs
Largest company Dr.Reddy's Laboratories Ltd · ₹35,059 Cr (FY 2026)
Combined revenue ₹35,709 Cr across 15 companies
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dr.Reddy's Laboratories Ltd L85195TG1984PLC004507 | Whole-Time Director | 18 Jan 1993 | 1984 | ₹35,059 Cr (FY 2026) | Active |
 Greenpark Hotels And Resorts Limited U55101TG1986PLC006972 | Director | 29 Sep 1995 | 1986 | ₹282 Cr (FY 2024) | Active |
 Aurigene Oncology Limited U24239KA2001PLC029391 | Director | 10 Aug 2001 | 2001 | ₹172 Cr (FY 2025) | Active |
 Stamlo Industries Limited U73100TG1996PLC024085 | Director | 14 May 1996 | 1996 | ₹73.13 Cr (FY 2024) | Active |
 Araku Originals Private Limited U01119MH2008PTC282862 | Director | 04 Sep 2013 | 2008 | ₹41.12 Cr (FY 2025) | Active |
 Dr.Reddy's Institute Of Life Sciences U73100TG2003NPL042023 | Director | 24 Jun 2013 | 2003 | ₹22.14 Cr (FY 2025) | Active |
 Nayanta Education Foundation U80300TG2022NPL167423 | Director | 12 Oct 2022 | 2022 | ₹21.47 Cr (FY 2025) | Active |
| Nayanta Education Foundation U80300PN2022NPL254840 | Director | 12 Oct 2022 | 2022 | ₹21.47 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zenfold Ventures Llp AAO-2259 | Partner | 14 Mar 2022 | 2019 | ₹10.2 Lakh (FY 2023) | Active |
| Proline Real Estates Private Limited U70100AP1996PTC023977 | Director | 14 Mar 2002 | 1996 | – | Amalgamated |
| Cheminor Investments Ltd U67120TG1990PLC010931 | Director | 21 Apr 2010 | 1990 | ₹19.2 Lakh (FY 2025) | Active |
 Ecologic Technologies Limited U74900TG2008PLC058294 | Director | 09 Jul 2009 | 2008 | ₹8,449 (FY 2020) | Strike Off |
| Drl Impex Limited U65990TG1986PLC006695 | Director | 07 Dec 1994 | 1986 | ₹39.3 Lakh (FY 2025) | Active |
| Young President's Organisation Hyderabad Chapter U93000TG2007NPL055534 | Director | 26 Jul 2012 | 2007 | ₹4.52 Cr (FY 2026) | Active |
| Idea2enterprises (India) Private Limited U72200TG2000PTC034473 | Director | 12 Dec 2000 | 2000 | ₹1.43 Cr (FY 2025) | Active |
| Dr.Reddy's Research Foundation U73100TG1986GAP006218 | Director | 01 May 1993 | 1986 | ₹13.7 Lakh (FY 2025) | Active |
| I-Ven Pharma Capital Limited U24231KA2005PLC035853 | Director | 01 Oct 2010 | 2005 | – | Under Liquidation |
| Dr.Reddy's Holdings Limited U67120TG1994PLC017906 | Director | 12 Jul 1994 | 1994 | ₹103 Cr (FY 2021) | Amalgamated |
| Alanine Real Estates Private Limited U70100TG1996PTC023862 | Director | 22 Apr 1996 | 1996 | – | Amalgamated |
| Lansa Real Estates Private Limited U70100TG1996PTC024086 | Director | 14 Mar 2002 | 1996 | – | Amalgamated |
| Oxo Real Estates Private Limited U70100TG1996PTC024090 | Director | 15 May 1996 | 1996 | – | Amalgamated |
| Ibu Real Estates Private Limited U70100TG1996PTC024098 | Director | 15 May 1996 | 1996 | – | Amalgamated |
| Meditimes (India) Private Limited U72200TG1999PTC032168 | Director | 02 Aug 2000 | 1999 | – | Strike Off |
| Napro Real Estates Private Limited U70100TG1996PTC024087 | Director | 14 May 1996 | 1996 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Dr. Reddy's Bio-Sciences Limited
Dr.Reddy's Laboratories Ltd
Araku Originals Private Limited
I-Ven Pharma Capital Limited
Premium access
Shareholding and investment profile for Satish Reddy Kallam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satish Reddy Kallam
Satish Reddy Kallam has 33 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 22 companies, including Dr. Reddy's Bio-Sciences Limited and Dr.Reddy's Laboratories Ltd. Formerly with 29 companies, such as Zenfold Ventures Llp and Proline Real Estates Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 15 current companies with reported revenue have a combined latest revenue of ₹35,709 Cr; the largest is Dr.Reddy's Laboratories Ltd at ₹35,059 Cr (FY 2026).
Satish Reddy Kallam is associated with 22 companies as Director and Whole-Time Director, including Dr.Reddy's Laboratories Ltd (₹35,059 Cr), Greenpark Hotels And Resorts Limited (₹282 Cr), Aurigene Oncology Limited (₹172 Cr).
Satish Reddy Kallam has expertise in General Business, Technology.
Satish Reddy Kallam has 33 years in corporate governance.
By reported revenue, the largest current company of Satish Reddy Kallam is Dr.Reddy's Laboratories Ltd, with revenue of ₹35,059 Cr (FY 2026).
The 15 current companies of Satish Reddy Kallam that report revenue have a combined latest revenue of ₹35,709 Cr.
Satish Reddy Kallam currently holds positions at 22 companies; the 5 largest by reported revenue are Dr.Reddy's Laboratories Ltd (₹35,059 Cr), Greenpark Hotels And Resorts Limited (₹282 Cr), Aurigene Oncology Limited (₹172 Cr), Stamlo Industries Limited (₹73.13 Cr), Araku Originals Private Limited (₹41.12 Cr).